2seventy bio, Inc.
TSVTDelisted May 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860782
2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding 2seventy bio, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 116 | 2 | 117 | +3 |
| Shares | 48.2M | 53 | 46.8M | −1.41M (−2.9%) |
| Value | $205.8M | $85 | $250.9M | +$45.2M (+22.0%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held 2seventy bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 1,736,600 | $9.29M | 0.03% |
| Jacobs Levy Equity Management, Inc | 379,586 | $2.03M | 0.01% |
| Susquehanna Fundamental Investments, LLC | 138,243 | $739.6K | 0.03% |
| HighVista Strategies LLC | 93,500 | $500.2K | 0.18% |
| Wedmont Private Capital | 85,934 | $483.8K | 0.04% |
| State of Wisconsin Investment Board | 62,400 | $333.8K | 0.00% |
| Martingale Asset Management L P | 45,158 | $241.6K | 0.00% |
| Balyasny Asset Management LLC | 38,434 | $205.6K | 0.00% |
| PDT Partners, LLC | 26,793 | $143.3K | 0.01% |
| BBR Partners, LLC | 15,000 | $80.3K | 0.01% |
| Graham Capital Management, L.P. | 12,309 | $65.9K | 0.00% |
| Franklin Resources Inc | 10,635 | $56.9K | 0.00% |
| SkyView Investment Advisors, LLC | 10,000 | $54.0K | 0.01% |
| Fernwood Investment Management, LLC | 666 | $3.56K | 0.00% |
| Capital Analysts, LLC | 100 | $1.00K | 0.00% |
| Trust Co of Vermont | 83 | $444 | 0.00% |
| GAMMA Investing LLC | 28 | $150 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 10 | $53 | 0.00% |
Sold out (15)
Institutions that held 2seventy bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,331,801 | $5.69M |
| Woodline Partners LP | 958,682 | $4.09M |
| Acadian Asset Management LLC | 275,716 | $1.18M |
| Panagora Asset Management Inc | 212,982 | $909.4K |
| Captrust Financial Advisors | 116,898 | $499.2K |
| Pale Fire Capital SE | 40,688 | $173.7K |
| Triton Wealth Management, PLLC | 42,248 | $155.1K |
| Squarepoint Ops LLC | 23,164 | $98.9K |
| Two Sigma Investments, LP | 11,100 | $47.4K |
| Diversified Trust Co | 10,379 | $44.3K |
| Belvedere Trading LLC | 8,471 | $36.2K |
| Quest Partners LLC | 5,699 | $24.3K |
| Advisory Services Network, LLC | 216 | $922 |
| Boyd Watterson Asset Management LLC | 41 | $175 |
| Rocky Mountain Advisers, LLC | 6 | $26 |
Not filed for Q1 2024 yet (2)
Institutions that held 2seventy bio, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Fairfield Financial Advisors, LTD | 20 | $85 |
| Bartlett & Co. LLC | 33 | $0 |